(a) Baseline profiles
Outcome ESWT group Sham group valueNo. of patients 19 18 VAS 6.0 (5.0, 7.8) 5.5 (3.3, 7.8) 0.807 Muscle power (lb) 15.0 (14.0, 20.0) 15.0 (13.25, 15.75) 0.089 CMS 44.0 (40.0, 55.0) 44.5 (37.25, 52.25) 0.470
(b) One week after intervention
Outcome ESWT group Sham group valueNo. of patients 19 18 VAS 5.0 (4.0, 7.0) 5.5 (3.0, 6.8) 0.640 Muscle power (lb) 16.5 (15.0, 20.75) 15.0 (13.0, 17.0) 0.051 CMS 52.5 (45.5, 60.5) 52.5 (45.0, 58.75) 0.450
(c) Four weeks after intervention
Outcome ESWT group Sham group valueNo. of patients 19 17 VAS 5.0 (2.3, 7.0) 3.0 (2.0, 6.0) 0.467 Muscle power (lb) 18.0 (15.0, 20) 16.0 (14.0, 18.0) 0.252 CMS 60.0 (50.5, 71.0) 57.0 (54.0, 67.0) 0.430
(d) Three months after intervention
Outcome ESWT group Sham group valueNo. of patients 18 15 VAS 1.0 (0.0, 2.0) 3.0 (1.5, 4.0) 0.089 Muscle power (lb) 18.5 (16.0, 20.0) 16.0 (15.0, 19.0) 0.199 CMS 76.0 (59.0, 82.5) 70.0 (57.5, 72.5) 0.160
(e) Six months after intervention
Outcome ESWT group Sham group valueNo. of patients 16 15 VAS 0.0 (0.0, 0.3) 1.0 (0.0, 2.0) 0.012 Muscle power (lb) 20.0 (19.5, 20.0) 18.0 (16.5, 20.0) 0.034 CMS 87.0 (77.5, 91.0) 76.0 (71.3, 78.8) 0.026
(f) 12 months after intervention
Outcome ESWT group Sham group valueNo. of patients 16 15 VAS 0.0 (0.0, 0.0) 0.5 (0.0, 2.0) 0.025 Muscle power (lb) 20.0 (20.0, 22.3) 17.5 (16.0, 20.0) 0.002 CMS 91.5 (89.8, 95.0) 85.0 (72.0, 87.0) 0.005
CMS: Constant and Murley score; ESWT: extracorporeal shockwave therapy; VAS: visual analogue scale.